主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MBRX
#4445
Moleculin Biotech, Inc.
2.040
0
USD
0.00%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
0.00%
每月变动
-35.24%
6个月变化
-35.24%
年变化
-35.24%
前一天收盘价
2.040
0
Open
2.020
0
Bid
2.040
0
Ask
2.043
0
Low
2.005
0
High
2.110
0
交易量
83
市场
股票
医疗保健
MBRX
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
120.08 K
560.02 K
565.1 K
1.21 M
2.04 M
—
Valuation ratios
Enterprise value
-9.06 M
-3.33 M
-7.17 M
-7.19 M
-5.62 M
-23.31 M
Price to earnings ratio
-0
-0.01
0.01
0.01
-0.01
-0.01
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-0
-0.01
-0.01
-0
-0.01
-0.03
Price to book ratio
0
0.04
0
0
0.04
0.08
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.32
0.14
0.31
0.38
1.25
2.07
Return on equity %
0.99
0.38
153.24
1.14
0.94
155.71
Return on invested capital %
241.54
226
203.14
189.17
189.11
807.42
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.08
0.97
1.35
1.15
1.39
4.86
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
41.15
36.91
12.21
8.99
4.84
62.95
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
63.3
31.06
20.64
12.17
4.49
68.37
Net current asset value per share
78.12
37.71
24.99
14.61
5.28
82.6
Tangible book value per share
-24.7
-37.53
-29.71
-6.41
10.57
-63.09
Working capital per share
40.47
-1.2
6.54
1.87
1.48
8.69
Book value per share
50.34
43.41
0.11
11.54
18.04
73.1
新闻
Moleculin Biotech releases CEO update on leukemia trial
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54%
美国股市收低;截至收盘道琼斯工业平均指数下跌0.54%
Moleculin Biotech股价因权证行权协议暴跌
Moleculin Biotech stock plunges after warrant exercise agreement
Moleculin Biotech通过权证行权筹资830万美元
Moleculin Biotech raises $8.3 million through warrant exercise
Moleculin Biotech股价上涨,AML药物试验显示出令人鼓舞的结果
Moleculin Biotech stock rises as AML drug trial shows promising results
Moleculin公布关键AML治疗试验早期数据,结果令人鼓舞
Moleculin reports promising early data in pivotal AML treatment trial
Moleculin Biotech获日本关键专利后股价上涨